June 22, 2021
World Intellectual Property Review
The Supreme Court of the United States’ Arthrex decision determined that Patent Trial and Appeal Board (PTAB) Administrative Patent Judges (APJs) were unconstitutionally appointed. As a remedy, the Supreme Court handed power to the U.S. Patent and Trademark Office (USPTO) director to assess inter partes review (IPR) decisions. World IP Review interviewed Finnegan partner Derek McCorquindale for his thoughts on the decision.
Derek said, “The director’s authority is executive and remains circumscribed to allow the U.S. President to maintain adequate control, including the power of direct removal. Additionally, any review conducted by the director will still be subject to judicial review at the United States Court of Appeals for the Federal Circuit.”
Read “Arthrex: ‘Patents Have Become More Political’”
United States v. Arthrex, Arthrex v. Smith & Nephew , Supreme Court of the United States (SCOTUS), Patent Trial and Appeal Board (PTAB), administrative patent judge (APJ)
Press Release
October 6, 2026
Commentary
Federal Circuit Revives Whistleblower Complaint Over VA's AI Claims-Processing Tool
September 25, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Award/Ranking
Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026
September 23, 2026
Press Release
Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower
September 23, 2026
Commentary
New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret
September 21, 2026
Commentary
FORUM IP Talks: Dr. Jochen Herr on UPC, FRAND, and Cross-Border Enforcement Topics
September 20, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.